Lataa...
Effect of liraglutide vs. placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: a randomized controlled trial
AIMS: To examine how circulating GLP-1 concentrations during liraglutide treatment relate to its therapeutic actions on glucose and weight, and to study the effects of liraglutide on other proglucagon-derived peptides (PGDPs), including endogenous GLP-1, GLP-2, glucagon, oxyntomodulin, glicentin, an...
Tallennettuna:
| Julkaisussa: | Diabetes Obes Metab |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7856054/ https://ncbi.nlm.nih.gov/pubmed/33140542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14242 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|